Request Demo
Last update 24 Jun 2025
PCNAT-01
Last update 24 Jun 2025
Overview
Basic Info
Drug Type Personalized antigen vaccine |
Synonyms PCANT-01, PCNAT-01, PCNAT-1 |
Target- |
Action- |
Mechanism- |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Login to view timeline
Related
2
Clinical Trials associated with PCNAT-01ChiCTR2500101598
An open-label, Phase I clinical study to evaluate the safety and tolerability of PCNAT-01 vaccine in subjects following radical resection and adjuvant therapy for pancreatic cancer
CTR20251525
一项评价PCNAT-01疫苗在胰腺癌根治性切除术及辅助治疗后受试者中的安全性、耐受性的开放标签、I期临床试验
[Translation] An open-label, Phase I clinical trial evaluating the safety and tolerability of PCNAT-01 vaccine in subjects with pancreatic cancer after radical resection and adjuvant therapy
100 Clinical Results associated with PCNAT-01
Login to view more data
100 Translational Medicine associated with PCNAT-01
Login to view more data
100 Patents (Medical) associated with PCNAT-01
Login to view more data
100 Deals associated with PCNAT-01
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pancreatic Cancer | Phase 1 | China | 25 Apr 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free